Dallas, TX (PRWEB) September 30, 2012 Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and even neural cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases and are immuno-privileged, which makes them an advantageous cell type for allogenic transplantation. In the market research report Mesenchymal Stem Cells Advances & Applications, trend analysis of grant activity, publications, and patent applications reveals that global research activity involving MSCs increased by 112% from 2009 to 2010, and by 116% from 2010 to 2011. This rate accelerated throughout 2011, positioning mesenchymal stem cells as the fastest growing area of stem cell research for 2012. While competitors are guessing, this report divulges exactly where to focus R&D and marketing spend to create the most profitable MSC research products. A key element of this report is survey findings from a large population of mesenchymal stem cell (MSC) researchers that reveals: It is also important for bio-pharmaceutical and pharma companies interested in MSC therapy applications to understand underlying market forces, and in … Continue reading →

Your greatest fear, if you are the parent of an adult child with a disability, is that you will not outlive your offspring and leave them to a world where they are not protected, cared for and loved. As The Star's series on autism showed, many families struggle as their autistic young people work to make that transition. Despite some good intentions, the state of California and insurance companies are frightening the parents of adult children with autism. In 2011, the Legislature passed SB 946, making our state one of the few that require health insurers to cover treatment for adults with autism. Autism remains a truly confounding condition and there is much to be learned about its causes and treatment. Through applied behavior, however, we have seen great improvements in living skills, communications skills and self-care skills. Parents were rightfully joyful when SB 946 passed. Their adult children would be covered by health insurance and they could get the treatment that could lead to independence or semi-independence. It hasn't worked out exactly that way, yet. In August, Vista Center for Behavior Analysis held a panel discussion, featuring experts in autism and insurance, for parents of adult children with Autism … Continue reading →

ScienceDaily (Sep. 28, 2012) The statistics show that efforts to reduce heart disease deaths are successful, with mortality now falling in most of the continent. At the same time, the report shows the huge burden CVD presents to Europe's health, and suggests that underlying factors may cause CVD to increase in the near future. The figures show some progress. Since the 2008 report there has been a substantial drop in the number of deaths attributed to heart disease. CVD is now responsible for four million European deaths annually, down from 4.3 million in 2008 (which represents a drop from 48% to 47% of total European deaths). Within the EU, it is responsible for 1.8 million deaths per year, down from two million in 2008 (40% of all EU deaths, down from 42%)2. Commenting, ESC President, Professor Panos Vardas said: "There is good news here, but it needs to be approached with some caution. Fewer lives are being lost to cardiovascular disease than in 2008. At the same time, the scale of the problem is enormous. CVD is still responsible for four million European deaths per year. This is a real human tragedy and a significant economic burden. We anticipate this … Continue reading →